Volume 14, Number 6—June 2008
Dispatch
High Failure Rates of Melarsoprol for Sleeping Sickness, Democratic Republic of Congo
Jo Robays*
, Gaspard Nyamowala†‡, Claude Sese†, Victor Betu Ku Mesu Kande†, Pascal Lutumba†§, Wim Van der Veken¶, and Marleen Boelaert*
, Gaspard Nyamowala†‡, Claude Sese†, Victor Betu Ku Mesu Kande†, Pascal Lutumba†§, Wim Van der Veken¶, and Marleen Boelaert*Table 2
Characteristics of 959 patients who experienced relapse after treatment with melarsoprol, Equateur Nord Province, 2001–2003
| Characteristic | No. (%) |
|---|---|
| Sex | |
| M | 433 (45.2) |
| F |
526 (54.8) |
| Age | |
| >1–11mo | 1 (0.1) |
| 12–59 mo | 13 (1.4) |
| 5–59 y | 936 (97.6) |
| >60 y |
9 (0.9) |
| Stage of disease | |
| First | 46 (4.8) |
| Second | 782 (81.5) |
| Unknown |
131 (13.7) |
| Parasites found | 259 (27.0) |
